IRA's Impact on Biopharma Innovation | Harvard Kennedy School
Description
December 2, 2022, Audio: "With the US Inflation Reduction Act now law, many in Washington DC are saying that it’s provisions reducing pricing by $80 billion dollars annually in Medicare for drugs near the end of their patent life will not have any negative impacts on the US biopharma ecosystem. Ent